NCT00599885View on ClinicalTrials.gov

Comparison of Effects of Telmisartan and Valsartan on Neointima Volume in Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

July 31, 2008

Conditions
HypertensionDiabetesCoronary Artery Disease
Interventions
DRUG

telmisartan

telmisartan 40-80mg once per day for 8 months

DRUG

valsartan

valsartan 80-160mg once per day for 8 months

Trial Locations (1)

136-705

Korea University Anam Hospital, Seoul

All Listed Sponsors
lead

Korea University Anam Hospital

OTHER

NCT00599885 - Comparison of Effects of Telmisartan and Valsartan on Neointima Volume in Diabetes | Biotech Hunter | Biotech Hunter